Open Access Policy

Haematology, Transfusion & Blood Science is an open-access, peer-reviewed journal that publishes original research, clinical studies, and reviews across the fields of haematology, transfusion medicine, and blood sciences. The journal serves as an international platform for clinicians, laboratory scientists, and researchers to share discoveries and innovations that enhance understanding, diagnosis, and treatment of haematological disorders and improve transfusion safety.

All published articles are made freely and permanently accessible online immediately upon publication without subscription fees or access charges for readers worldwide.

The journal supports the broad dissemination of scientific knowledge and engineering innovation through an open-access publishing model that ensures global visibility, accessibility, and long-term preservation of scholarly content.

Licensing and Copyright

All articles published in the journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).

Under this license, users are permitted to:

  • Read, download, copy, distribute, print, and share published articles
  • Adapt, remix, transform, and build upon the published work
  • Reuse the content for lawful commercial and non-commercial purposes

provided that appropriate credit is given to the original author(s) and source.

Author Rights

Authors retain copyright of their published work while granting the journal the right to publish, archive, and distribute the article as part of the scholarly record.

Accessibility and Knowledge Dissemination

The journal supports the global exchange of scientific knowledge by encouraging open, ethical, and responsible sharing of research to advance innovation in the fields of haematology, transfusion medicine, and blood sciences. The journal serves as an international platform for clinicians, laboratory scientists, and researchers to share discoveries and innovations that enhance understanding, diagnosis, and treatment of haematological disorders and improve transfusion safety.